Biorelate provides biomedical research services.
Biorelate has raised $7.8M in total funding. The most recent round was Series A. The last funding was announced in November 2022.
Biorelate's investors include Maven Capital Partners, Triple Point Ventures, YFM Equity Partners, Northern Powerhouse Investment Fund, GM&C Life Sciences Fund.
Biorelate is headquartered in Manchester, United Kingdom.
Biorelate provides biomedical research services.
Biorelate is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biorelate — Funding & Investors." VCBacked, November 29, 2022, https://www.vcbacked.co/company/biorelate. Accessed September 30, 2026.
VCBacked. (2022). Biorelate — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/biorelate
{{cite web |title=Biorelate — Funding & Investors |url=https://www.vcbacked.co/company/biorelate |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated